FDA Warning Letter — Henan Lvyuan Pharmaceutical Co., Ltd.

Case 722497 — FEI 3013253128

The FDA took a Warning Letter action against Henan Lvyuan Pharmaceutical Co., Ltd. on March 26, 2026 (Xinxiang, China). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
Henan Lvyuan Pharmaceutical Co., Ltd.
Date
March 26, 2026
Fiscal Year
2026
Product Type
Drugs
Center
CDER
Location
Xinxiang (China)